EMA approves Biocon Biologics’ new mAbs facility in India
Renews GMP certifications for India and Malaysia sites
Renews GMP certifications for India and Malaysia sites
Second FDA approval for KRAZATI - reinforcing its potential across tumor types
India's healthcare sector anticipates telemedicine reaching US$ 5.4 billion by 2025, with AI growing at 45% by 2024 and Healthtech jobs increasing 15-20%
Sapala has a strong customer base including innovator Pharma, CDMOs & diagnostic companies
Prior to taking charge at the Union Health Ministry, Jadhav planted a sapling at his residence
Innovative technologies and comprehensive services to strengthen Syntegon’s strategic growth
The state-of-the-art facility is equipped with best-in-class equipment and control systems
The Indian pharmaceutical industry is projected to reach US$ 130 billion by 2030
Strategic focus on India aims to make the Swoop® portable MR brain imaging system commercially available in a vast and underserved MRI market
Greg was also central to the planning, design, and construction of this facility
Subscribe To Our Newsletter & Stay Updated